RxDoctor Payments Data

Deanna Twyman

Family · Conway, MONPI 1164408399

Payments from drug & device makers

$1,687in general payments, 2019–2025

Across 102 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$410
  • GSK$234
  • AbbVie$176
  • Otsuka America Pharmaceutical, Inc.$171
  • Merck$135
  • Novo Nordisk$97
  • plus $463 from 13 others

What the payments were for

  • Food & beverage$1,67399%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,687 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban77$62,653
JardianceEmpagliflozin32$45,932
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$44,666
Breztri AerosphereBudesonide/Glycopyr/Formoterol40$38,332
RexultiBrexpiprazole21$34,728
FarxigaDapagliflozin Propanediol42$32,983
LinzessLinaclotide13$18,394
Breo ElliptaFluticasone/Vilanterol31$13,254
Spiriva HandihalerTiotropium Bromide14$13,251
XareltoRivaroxaban18$13,087
Stiolto RespimatTiotropium Br/Olodaterol Hcl21$10,480
OzempicSemaglutide11$9,498
Xigduo XrDapaglifloz Propaned/Metformin13$8,048
SymbicortBudesonide/Formoterol Fumarate24$7,839
Tresiba Flextouch U-100Insulin Degludec16$7,691

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$410$79,153106 claims
PfizerEliquis, Abrysvo$45$67,02396 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat$80$61,55564 claims
GSKTrelegy Ellipta, Breo Ellipta$234$57,92070 claims
Otsuka America Pharmaceutical, Inc.Rexulti$171$34,72821 claims
AbbVieLinzess$176$18,39413 claims
Johnson & JohnsonXarelto$51$13,08718 claims
Novo NordiskOzempic$97$9,49811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.

Other family in Conway

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →